MTOR and Huntington disease: Since mHTT is SUMOylated at multiple sites (34, 61) and enhances perinuclear association of mTOR in Huntington disease cells (36), we speculate that SUMOylation of mHTT may further facilitate mTOR signaling and affect disease progression in cooperation with SUMOylation of GβL in HD conditions.